Exo Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$77.8M
- Investors
-
12
Exo Therapeutics General Information
Description
Developer of a small-molecule therapeutics platform designed to target exosites and distal binding pockets that modulate enzyme activity for precise and potent therapeutic effects. The company's platform leverages a confluence of technologies that allow for seeing, modeling, building, designing, and discovering exosite-targeted small molecule drugs and can be applied across enzyme classes to discover therapeutic candidates across diseases, enabling healthcare institutions to expand the diversity of targets.
Contact Information
Website
www.exo-therapeutics.comCorporate Office
- 150 Cambridge Park Drive
- Suite 300
- Cambridge, MA 02140
- United States
Corporate Office
- 150 Cambridge Park Drive
- Suite 300
- Cambridge, MA 02140
- United States
Exo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 04-Oct-2021 | $77.8M | Completed | Clinical Trials - General | ||
| 2. Early Stage VC (Series A) | 16-Dec-2020 | Completed | Clinical Trials - General | |||
| 1. Accelerator/Incubator | Completed | Startup |
Exo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Exo Therapeutics Comparisons
Industry
Financing
Details
Exo Therapeutics Competitors (3)
One of Exo Therapeutics’s 3 competitors is Edgewise Therapeutics, a Formerly VC-backed company based in Boulder, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Edgewise Therapeutics | Formerly VC-backed | Boulder, CO | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| BioCryst Pharmaceuticals | Corporation | Durham, NC |
Exo Therapeutics Patents
Exo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021195183-A1 | Compositions and methods for inhibiting protein embryonic ectoderm development activity and treating disease | Inactive | 24-Mar-2020 |
Exo Therapeutics Signals
Exo Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 120 Capital | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Morningside Group | Venture Capital | Minority | ||
| Nextech Invest | Venture Capital | Minority |
Exo Therapeutics FAQs
-
When was Exo Therapeutics founded?
Exo Therapeutics was founded in 2018.
-
Where is Exo Therapeutics headquartered?
Exo Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Exo Therapeutics?
Exo Therapeutics has 17 total employees.
-
What industry is Exo Therapeutics in?
Exo Therapeutics’s primary industry is Drug Discovery.
-
Is Exo Therapeutics a private or public company?
Exo Therapeutics is a Private company.
-
What is the current valuation of Exo Therapeutics?
The current valuation of Exo Therapeutics is .
-
What is Exo Therapeutics’s current revenue?
The current revenue for Exo Therapeutics is .
-
How much funding has Exo Therapeutics raised over time?
Exo Therapeutics has raised $103M.
-
Who are Exo Therapeutics’s investors?
120 Capital, BVF Partners, Casdin Capital, Morningside Group, and Nextech Invest are 5 of 12 investors who have invested in Exo Therapeutics.
-
Who are Exo Therapeutics’s competitors?
Edgewise Therapeutics, Sarepta Therapeutics, and BioCryst Pharmaceuticals are competitors of Exo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process